We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the... Apellis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3 the central protein in the complement cascade. Show more
WALTHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a...
WALTHAM, Mass., April 01, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a fireside chat at the 23rd Annual Needham Virtual...
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that leading retina specialist Philip Ferrone, M.D., will join the company as...
WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.12 | -7.95981452859 | 51.76 | 53.06 | 46.4 | 1685677 | 49.37028715 | CS |
4 | -7.58 | -13.7269105397 | 55.22 | 59.91 | 46.4 | 1201801 | 53.68442072 | CS |
12 | -15.73 | -24.8224712009 | 63.37 | 71.9 | 46.4 | 1341212 | 60.95953483 | CS |
26 | 1.62 | 3.52020860495 | 46.02 | 73.8 | 41.19 | 1805427 | 58.05013998 | CS |
52 | -37.84 | -44.2676649509 | 85.48 | 94.75 | 19.8301 | 2640710 | 50.82407536 | CS |
156 | 1.54 | 3.34056399132 | 46.1 | 94.75 | 19.8301 | 1734506 | 51.40642036 | CS |
260 | 28.76 | 152.330508475 | 18.88 | 94.75 | 16.85 | 1348360 | 47.51604455 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions